CoChat
Sign Up
Cited by 192Epigenetics and DNA MethylationNutrition, Genetics, and DiseaseGenetics, Aging, and Longevity in Model Organisms

The DOI matches its Crossref record; 343 of the 343 references it cites were found in a registry or an index.

From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition?

Open access
vel Szic, Katarzyna Szarc, Declerck, Ken, Vidaković, Melita, Vanden Berghe, Wim·2015·Clinical Epigenetics
DOI 10.1186/s13148-015-0068-2PMC PMC4389409
Open this paper in CoChat — free accountOpen PDF

Abstract

The progressively older population in developed countries is reflected in an increase in the number of people suffering from age-related chronic inflammatory diseases such as metabolic syndrome, diabetes, heart and lung diseases, cancer, osteoporosis, arthritis, and dementia. The heterogeneity in biological aging, chronological age, and aging-associated disorders in humans have been ascribed to different genetic and environmental factors (i.e., diet, pollution, stress) that are closely linked to socioeconomic factors. The common denominator of these factors is the inflammatory response. Chronic low-grade systemic inflammation during physiological aging and immunosenescence are intertwined in the pathogenesis of premature aging also defined as 'inflammaging.' The latter has been associated with frailty, morbidity, and mortality in elderly subjects. However, it is unknown to what extent inflammaging or longevity is controlled by epigenetic events in early life. Today, human diet is believed to have a major influence on both the development and prevention of age-related diseases. Most plant-derived dietary phytochemicals and macro- and micronutrients modulate oxidative stress and inflammatory signaling and regulate metabolic pathways and bioenergetics that can be translated into stable epigenetic patterns of gene expression. Therefore, diet interventions designed for healthy aging have become a hot topic in nutritional epigenomic research. Increasing evidence has revealed that complex interactions between food components and histone modifications, DNA methylation, non-coding RNA expression, and chromatin remodeling factors influence the inflammaging phenotype and as such may protect or predispose an individual to many age-related diseases. Remarkably, humans present a broad range of responses to similar dietary challenges due to both genetic and epigenetic modulations of the expression of target proteins and key genes involved in the metabolism and distribution of the dietary constituents. Here, we will summarize the epigenetic actions of dietary components, including phytochemicals, and macro- and micronutrients as well as metabolites, that can attenuate inflammaging. We will discuss the challenges facing personalized nutrition to translate highly variable interindividual epigenetic diet responses to potential individual health benefits/risks related to aging disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13148-015-0068-2

Cites

343 of 343 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Metabolic pathways generate essential metabolites for chromatin- and DNA-modifying enzymes. NAD, acetyl-coenzyme A (Acetyl-coA), and S-adenosylmethionine (SAM) are elemental for epigenetic control of transcription including methylation of DNA and posttranslational modifications of histones and non-histone chromatin factors (not shown). NAD contributes to transcriptional control mainly via the activity of the protein deacetylase sirtuin, which uses NAD as one of the substrates. Sirtuins are also important for maintaining the activity of the acetyl-coA acetyltransferases. Acetyl-coA is synthesized by acetyl-coA-synthetase (ACS) and ATP-citrate lyase that use acetate and citrate as the precursors, respectively. Citrate is an intermediate/product of the TCA cycle. SAM is the methyl donor for DNA, RNA, histones, and non-histone protein methylation. S-adenosylhomocysteine (SAH) generated in each round of methylation reaction is a potent inhibitor of methyltransferases and has to be cleared by SAH hydrolase (SAHH). NAD is an essential coenzyme for SAHH. Synthesis of methionine from homocystein is achieved through extracting the methyl group from betaine, derived from choline, or 5-methyl-THF, a derivative of folic acid. Metabolism of phospholipids and folic acid may thus indirectly contribute to epigenetic regulation. Likewise, the abundance of NAD and citrate is linked to the cellular energy flux, e.g., the TCA cycle. Changes in the expression of certain genes may therefore be influenced significantly. Abbreviations used: Acetyl-coA, acetyl-coenzyme A; ACS, acetyl-coA-synthetase; AC-ACS acetylated-ACS; Ado, adenosine; HAT, histone acetyltransferase; Hcy homocysteine; MTases, methyltransferases; NAD, Nicotinamide adenine dinucleotide; ROS, reactive oxygen species, RNS, reactive nitrogen species, SAH, S-adenosyl homocysteine; TCA, tricarboxylic cycle; THF, tetrahydrofolate.
Figure 1 Metabolic pathways generate essential metabolites for chromatin- and DNA-modifying enzymes. NAD, acetyl-coenzyme A (Acetyl-coA), and S-adenosylmethionine (SAM) are elemental for epigenetic control of transcription including methylation of DNA and posttranslational modifications of histones and non-histone chromatin factors (not shown). NAD contributes to transcriptional control mainly via the activity of the protein deacetylase sirtuin, which uses NAD as one of the substrates. Sirtuins are also important for maintaining the activity of the acetyl-coA acetyltransferases. Acetyl-coA is synthesized by acetyl-coA-synthetase (ACS) and ATP-citrate lyase that use acetate and citrate as the precursors, respectively. Citrate is an intermediate/product of the TCA cycle. SAM is the methyl donor for DNA, RNA, histones, and non-histone protein methylation. S-adenosylhomocysteine (SAH) generated in each round of methylation reaction is a potent inhibitor of methyltransferases and has to be cleared by SAH hydrolase (SAHH). NAD is an essential coenzyme for SAHH. Synthesis of methionine from homocystein is achieved through extracting the methyl group from betaine, derived from choline, or 5-methyl-THF, a derivative of folic acid. Metabolism of phospholipids and folic acid may thus indirectly contribute to epigenetic regulation. Likewise, the abundance of NAD and citrate is linked to the cellular energy flux, e.g., the TCA cycle. Changes in the expression of certain genes may therefore be influenced significantly. Abbreviations used: Acetyl-coA, acetyl-coenzyme A; ACS, acetyl-coA-synthetase; AC-ACS acetylated-ACS; Ado, adenosine; HAT, histone acetyltransferase; Hcy homocysteine; MTases, methyltransferases; NAD, Nicotinamide adenine dinucleotide; ROS, reactive oxygen species, RNS, reactive nitrogen species, SAH, S-adenosyl homocysteine; TCA, tricarboxylic cycle; THF, tetrahydrofolate.CC BY · PubMed Central
Figure 2 Plant phytochemicals achieve hormesis through multifocal pathway inhibition. Our health strongly benefits from interactions of a large number of plant molecules in our diet with key regulators of mammalian physiology (adapted from [288]). Various plant-derived molecules are synthesized as secondary metabolites in response to stress. During adversity in the context of particular environmental stresses, animals have retained the ability to sense these stress signaling molecules synthesized by their distant ancestors, through enzymes and receptors which regulate inflammation-energy-metabolism pathways to protect and to increase the survival of the organism. Abbreviations used: PKC, protein kinase C; PKD, protein kinase D, IKK2, inhibitor of IkB kinase 2; ROS/RNS, reactive oxygen/nitrogen species; NR, nuclear receptor; AMPK, AMP-activated protein kinase; TSC, tuberous sclerosis complex mTOR, mammalian target of rapamycin; R6SK ribosomal S6 kinase; PI3K, phosphoinositide 3-kinase; PDK, pyruvate dehydrogenase kinase; AKT/PKB, protein kinase B; PGC1, peroxisome proliferator-activated receptor c coactivator 1; SIRT, sirtuin; FOXO, forkhead box O.
Figure 2 Plant phytochemicals achieve hormesis through multifocal pathway inhibition. Our health strongly benefits from interactions of a large number of plant molecules in our diet with key regulators of mammalian physiology (adapted from [288]). Various plant-derived molecules are synthesized as secondary metabolites in response to stress. During adversity in the context of particular environmental stresses, animals have retained the ability to sense these stress signaling molecules synthesized by their distant ancestors, through enzymes and receptors which regulate inflammation-energy-metabolism pathways to protect and to increase the survival of the organism. Abbreviations used: PKC, protein kinase C; PKD, protein kinase D, IKK2, inhibitor of IkB kinase 2; ROS/RNS, reactive oxygen/nitrogen species; NR, nuclear receptor; AMPK, AMP-activated protein kinase; TSC, tuberous sclerosis complex mTOR, mammalian target of rapamycin; R6SK ribosomal S6 kinase; PI3K, phosphoinositide 3-kinase; PDK, pyruvate dehydrogenase kinase; AKT/PKB, protein kinase B; PGC1, peroxisome proliferator-activated receptor c coactivator 1; SIRT, sirtuin; FOXO, forkhead box O.CC BY · PubMed Central
Figure 3 Activity of chromatin modifying writer-eraser enzymes depends on available concentrations of cofactor metabolites and environmental signals. (A) Schematic representation of a nucleosome with extruding histone tails with residues that can be modified by various chromatin writer (i.e., DNA methyltransferase (DNMT), histone methyltransferase (HMT), histone acetylase (HAT), ubiquitin ligase (L), kinase (K), glycosylase (G)) or chromatin eraser enzymes (i.e., DNA hydroxymethylase (TET), demethylase (HDMT), deacetylase (HDAC), proteasome (Pr), phosphatase (PP)), resulting in dynamic histone methylation (Me), acetylation (Ac), ubiquitination (Ub), phosphorylation (P), and glycosylation (Gly). These histone modifications have been associated with changes in chromatin organization, gene activation, silencing, and several other nuclear functions (adapted from [338]). (B) Hypothetical model of a glycolytic-oxidative metabolic switch and its possible influence on epigenetic modifiers and the epigenetic landscape (adapted from [339]).
Figure 3 Activity of chromatin modifying writer-eraser enzymes depends on available concentrations of cofactor metabolites and environmental signals. (A) Schematic representation of a nucleosome with extruding histone tails with residues that can be modified by various chromatin writer (i.e., DNA methyltransferase (DNMT), histone methyltransferase (HMT), histone acetylase (HAT), ubiquitin ligase (L), kinase (K), glycosylase (G)) or chromatin eraser enzymes (i.e., DNA hydroxymethylase (TET), demethylase (HDMT), deacetylase (HDAC), proteasome (Pr), phosphatase (PP)), resulting in dynamic histone methylation (Me), acetylation (Ac), ubiquitination (Ub), phosphorylation (P), and glycosylation (Gly). These histone modifications have been associated with changes in chromatin organization, gene activation, silencing, and several other nuclear functions (adapted from [338]). (B) Hypothetical model of a glycolytic-oxidative metabolic switch and its possible influence on epigenetic modifiers and the epigenetic landscape (adapted from [339]).CC BY · PubMed Central
Figure 4 Overview of the mechanisms and consequences of epigenetic regulation by nutritional compounds. Modulation of different classes of chromatin writers-erasers by phytochemicals (left panel). Genes encoding absorption, distribution, metabolism, and excretion (ADME) proteins can be epigenetically regulated and thereby determine individual nutritional responses. Epigenetic modification of disease-related genes can contribute to diagnosis (biomarker) as well as disease prevention or progression (right panel).
Figure 4 Overview of the mechanisms and consequences of epigenetic regulation by nutritional compounds. Modulation of different classes of chromatin writers-erasers by phytochemicals (left panel). Genes encoding absorption, distribution, metabolism, and excretion (ADME) proteins can be epigenetically regulated and thereby determine individual nutritional responses. Epigenetic modification of disease-related genes can contribute to diagnosis (biomarker) as well as disease prevention or progression (right panel).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Items 201–343 of 343

Research works printed but not linked: 1

  1. Luo J, Kuo MH. Linking nutrient metabolism to epigenetics. Cell Sci Rev. 2009;6:49–54.

Cited by

Sorted by citations

See all 192

Related

See all

Metadata

Authors
vel Szic, K. S., Declerck, K., Vidaković, M., & Vanden Berghe, W.
Affiliations
  • University of Antwerp (BE)
  • University of Belgrade (RS)
Corresponding author
  • Declerck, Ken
  • Vidaković, Melita
ORCID
Venue
Clinical Epigenetics
Publisher
Springer Science and Business Media LLC
Published
2015-03-25
Volume
7
Issue
1
Pages
33-33
ISSN
  • 1868-7075 (ISSN-L)
  • 1868-7083
DOI
10.1186/s13148-015-0068-2
PMC
PMC4389409
OpenAlex
W2062149404
Cited by
192
References
343
Citations by year
2026: 9 · 2025: 14 · 2024: 11 · 2023: 8 · 2022: 12 · 2021: 20 · 2020: 14 · 2019: 23 · 2018: 20 · 2017: 21 · 2016: 31 · 2015: 9
FWCI
11.73
Type
journal article
Language
en
Open access
Licence
Locations
  • Clinical Epigenetics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Fonds Wetenschappelijk Onderzoek
  • Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (173020)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Nutrition, Genetics, and Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
inflammaging, healthy aging, epigenetics, personalized nutrition, dietary phytochemicals, macro and micronutrients, DNA methylation, histone modifications, non-coding RNA, chromatin remodeling, immunosenescence, dietary metabolites, oxidative stress

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review